[1] 陶桂香, 徐洋. 1型糖尿病发病机制及治疗研究[J]. 中国免疫学杂志, 2015, 31(10):1297-1303.
[2] YANG Z, CHEN M, FIALKOW L B, et al. The novel anti-inflammatory compound, lisofylline, prevents diabetes in multiple low-does streptozotocin-treated mice[J]. Pancreas, 2003, 26(4):99-104.
[3] HIRIDIS S, KONSTANTINIDIS K, MENENAKOS E, et al. Preliminary results of the influence of duodenojejunal bypass in a porcine model of streptozotocin-induced diabetes mellitus[J]. Obes Surg, 2016, 26(4):882-890.
[4] CHOI W S, KWON O S, CHO S Y, et al. Effect of chronic administration of PDE5 combined with glycemic control on erectile function in streptozotocin-induced diabetic rats[J]. J Sex Med, 2015, 12(3):600-610.
[5] 郑国亚, 连波, 刘顺梅, 等. 单次大剂量和多次小剂量STZ诱导昆明小鼠1型糖尿病模型的探究[J]. 中国生化医药杂志, 2015, 35(12):13-16.
[6] 谭壮生, 李芳, 张懿. 四氧嘧啶制备小鼠糖尿病模型的影响因素初探[J]. 毒理学杂志, 2013, 3(3):215-218.
[7] TAI N, WONG F S, WEN L. The role of the innate immune system in destruction of pancreatic beta cells in NOD mice and humans with type I diabetes[J]. J Autoimmun, 2016, 71:26-34.
[8] AL-AWAR A, KUPAI K, VESZELKA M, et al. Experimental diabetes mellitus in different animal models[J]. J Diabetes Res, 2016, 2016:1-12.
[9] OP DE BEEK A, EIZIRIK D L. Viral infections in type 1 diabetes mellitus-why the β cells?[J]. Nat Rev Endocrinol, 2016, 12(5):263-273.
[10] RENNER S, BLUTKE A, STRECKEL E, et al. Incretin actions and consequences of incretin-based therapies:lessons from complementary animal models[J]. J Pathol, 2016, 238(2):345-358.
[11] RENNER S, DOBENECKER B, BLUTKE A, et al. Comparative aspects of rodent and nonrodent animal models for mechanistic and translational diabetes research[J]. Theriogenology, 2016, 86(1):406-421.
[12] 朱华, 刘颖, 马春梅, 等. STZ诱导恒河猴糖尿病动物模型的建立[J]. 中国比较医学杂志, 2012, 22(6):53-56.
[13] PODELL B K, ACKART D F, RICHARDSON M A, et al. A model of type 2 diabetes in the guinea pig using sequential diet-induced glucose intolerance and streptozotocin treatment[J]. Dis Model Mech, 2017, 10(2):151-162.
[14] LUMELSKY N, BLONDEL O, LAENG P, et al. Differentiation of embryonic stem cell to insulin-secreting structures similar to pancreatic islets[J]. Science, 2001, 293(5529):1389-1394.
[15] REZANIA A, BRUIN J E, XU J, et al. Enrichment of human embryonic stem cell-derived NKX6.1-expressing pancreatic progenitor cells accelerates the maturation of insulin-secreting cells in vivo[J]. Stem Cells, 2013, 31(11):2432-2442.
[16] REN M, YAN L, SHANG C Z, et al. Effects of sodium butyrate on the differentiation of pancreatic and hepatic progenitor cells from mouse embryonic stem cells[J]. J Cell Biochem, 2010, 109(1):236-244.
[17] LI H, LAM A, XU A, et al. High dosage of exendin-4 increased early insulin secretion in differentiated beta cells from mouse embryonic stem cells[J]. Acta Pharmacol Sin, 2010, 31(5):570-577.
[18] ALIPIO Z, LIAO W, ROEMER E J, et al. Reversal of hyperglycemia in diabetic mouse models using induced-pluripotent stem (iPS)-derived pancreatic beta-like cells[J]. Proc Natl Acad Sci USA, 2010, 107(30):13426-13431.
[19] ZHU F F, ZHANG P B, ZHANG D H, et al. Generation of pancreatic insulin-producing cells from rhesus monkey induced pluripotent stem cells[J]. Diabetologia, 2011, 54(9):2325-2336.
[20] ZONG Y, STANGER B Z. Molecular mechanisms of bile duct development[J]. Int J Biochem Cell Biol, 2011, 43(2):257-264.
[21] TEO A K, TSUNEYOSHI N, HOON S, et al. PDX1 binds and represses hepatic genes to ensure robust pancreatic commitment in differentiating human embryonic stem cells[J]. Stem Cell Reports, 2015, 4(4):578-590.
[22] SMUKLER S R, ARNTFIELD M E, RAZAVI R, et al. The adult mouse and human pancreas contain rare multipotent stem cells that express insulin[J]. Cell Stem Cell, 2011, 8(3):281-293.
[23] ZHOU Q, BROWN J, KANAREK A, et al. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells[J]. Nature, 2008, 455(7213):627-632.
[24] NESHATI Z, MATIN M M, BAHRAMI A R, et al. Differentiation of mesenchymal stem cells to insulin-producing cells and their impact on type 1 diabetic rats[J]. J Physiol Biochem, 2010, 66(2):181-187.
[25] DAVIES L C, ALM J J, HELDRING N, et al. Type 1 diabetes mellitus donor mesenchymal stromal cells exhibit comparable potency to healthy controls in vitro[J]. Stem Cells Transl Med, 2016, 5(11):1485-1495.
[26] ROHBAN R, PIEBER T R. Mesenchymal stem and progenitor cells in regeneration:tissue specificity and regenerative potential[J]. Stem Cells Int, 2017(6):5173732.
[27] LEE R H, SEO M J, REGER R L, et al. Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice[J]. Proc Natl Acad Sci USA, 2006, 103(46):17438-17443. |
